Endothelin-1 enhances cell migration via matrix metalloproteinase-9 up-regulation in brain astrocytes

Journal of Neurochemistry

Volumn 113, Issue 5, 2010, Pages 1133-1149

  Wang, Hui Hsin ^a   Hsieh, Hsi Lung ^b   Wu, Cheng Ying ^a   Yang, Chuen Mao ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

AP 1; Astrocytes; Elk 1; Endothelin 1; Matrix metalloproteinases; NF B; P42 p44 mitogen activated protein kinase

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; ETS LIKE KINASE; GELATINASE B; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C FOS; PROTEIN C JUN; PROTEIN P42; PROTEIN P44; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; ASTROCYTE; BINDING SITE; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSCRIPTION; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; BRAIN; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MATRIX METALLOPROTEINASE 9; PLASMIDS; PROMOTER REGIONS, GENETIC; PROTEIN MODIFICATION, TRANSLATIONAL; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; UP-REGULATION;

EID: 77951888662     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06680.x     Document Type: Article

References (64)

1. Aoki T., Sumii T., Mori T., Wang X. Lo E. H. (2002) Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury mechanical versus embolic focal ischemia in spontaneously hypertensive rats. Stroke 33, 2711 2717. (Pubitemid 35266446)
2. Banerjee S., Hussain M., Wang Z., Saliganan A., Che M., Bonfil D., Cher M. Sarkar F. H. (2007) In vitro and in vivo molecular evidence for better therapeutic efficacy of ABT-627 and taxotere combination in prostate cancer. Cancer Res. 67, 3818 3826. (Pubitemid 46762169)
3. Böhm F. Pernow J. (2007) The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc. Res. 76, 8 18. (Pubitemid 47362047)
4. Byun H. J., Hong I. K., Kim E., Jin Y. J., Jeoung D. I., Hahn J. H., Kim Y. M., Park S. H. Lee H. (2006) A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways. J. Biol. Chem. 281, 34833 34847. (Pubitemid 46036523)
5. Castañares C., Redondo-Horcajo M., Magán-Marchal N., ten Dijke P., Lamas S. Rodríguez-Pascual F. (2007) Signaling by ALK5 mediates TGF-β-induced ET-1 expression in endothelial cells: a role for migration and proliferation. J. Cell Sci. 120, 1256 1266. (Pubitemid 46711844)
6. Cazaubon S., Chaverot N., Romero I. A., Girault J. A., Adamson P., Strosberg A. D. Couraud P. O. (1997) Growth factor activity of endothelin-1 in primary astrocytes mediated by adhesion-dependent and -independent pathways. J. Neurosci. 17, 6203 6212. (Pubitemid 27329895)
7. Chen P., Shibata M., Zidovetzki R., Fisher M., Zlokovic B. V. Hofman F. M. (2001) Endothelin-1 and monocyte chemoattractant protein-1 modulation in ischemia and human brain-derived endothelial cell cultures. J. Neuroimmunol. 116, 62 73. (Pubitemid 32322640)
8. Daher Z., Noël J. Claing A. (2008) Endothelin-1 promotes migration of endothelial cells through the activation of ARF6 and the regulation of FAK activity. Cell. Signal. 20, 2256 2265.
9. De Alvaro C., Teruel T., Hernandez R. Lorenzo M. (2004) Tumor necrosis factor α produces insulin resistance in skeletal muscle by activation of inhibitor κB kinase in a p38 MAPK-dependent manner. J. Biol. Chem. 279, 17070 17078. (Pubitemid 38560462)
10. De Lagausie P., de Buys-Roessingh A., Ferkdadji L. et al. (2005) Endothelin receptor expression in human lungs of newborns with congenital diaphragmatic hernia. J. Pathol. 205, 112 118. (Pubitemid 40029099)
11. Didier N., Romero I. A., Créminon C., Wijkhuisen A., Grassi J. Mabondzo A. (2003) Secretion of interleukin-1β by astrocytes mediates endothelin-1 and tumour necrosis factor-α effects on human brain microvascular endothelial cell permeability. J. Neurochem. 86, 246 254. (Pubitemid 36753865)
12. Eberhardt W., Schulze M., Engels C., Klasmeier E. Pfeilschifter J. (2002) Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-κB and Ets transcription factors. Mol. Endocrinol. 16, 1752 1766. (Pubitemid 34828086)
13. Felx M., Guyot M. C., Isler M., Turcotte R. E., Doyon J., Khatib A. M., Leclerc S., Moreau A. Moldovan F. (2006) Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-κB in human osteosarcoma. Clin. Sci. (Lond) 110, 645 654. (Pubitemid 43844734)
14. Gadea A., Schinelli S. Gallo V. (2008) Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK&c-Jun signaling pathway. J. Neurosci. 28, 2394 2408. (Pubitemid 351348181)
15. Ghosh S. Hayden M. S. (2008) New regulators of NF-κB in inflammation. Nat. Rev. Immunol. 8, 837 848.
16. Gu Z., Cui J., Brown S., Fridman R., Mobashery S., Strongin A. Y. Lipton S. A. (2005) A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J. Neurosci. 25, 6401 6408. (Pubitemid 40962536)
17. Guo S. Lo E. H. (2009) Dysfunctional cell-cell signaling in the neurovascular unit as a paradigm for central nervous system disease. Stroke 40, S4 S7.
18. Harkness K. A., Adamson P., Sussman J. D., Davies-Jones G. A., Greenwood J. Woodroofe M. N. (2000) Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain 123, 698 709. (Pubitemid 30162719)
19. Harris J. E., Nuttall R. K., Elkington P. T., Green J. A., Horncastle D. E., Graeber M. B., Edwards D. R. Friedland J. S. (2007) Monocyte-astrocyte networks regulate matrix metalloproteinase gene expression and secretion in central nervous system tuberculosis in vitro and in vivo. J. Immunol. 178, 1199 1207.
20. Hasselblatt M., Lewczuk P., Löffler B. M., Kamrowski-Kruck H., von Ahsen N., Sirén A. L. Ehrenreich H. (2001) Role of the astrocytic ET(B) receptor in the regulation of extracellular endothelin-1 during hypoxia. Glia 34, 18 26. (Pubitemid 32329028)
21. He S., Prasanna G. Yorio T. (2007) Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes. Invest. Ophthalmol. Vis. Sci. 48, 3737 3745. (Pubitemid 351261112)
22. Hsieh H. L., Yen M. H., Jou M. J. Yang C. M. (2004) Intracellular signalings underlying bradykinin-induced matrix metalloproteinase-9 expression in rat brain astrocyte-1. Cell. Signal. 16, 1163 1176.
23. Hsieh H. L., Wu C. Y. Yang C. M. (2008) Bradykinin induces matrix metalloproteinase-9 expression and cell migration through a PKC--dependent ERK&Elk-1 pathway in astrocytes. Glia 56, 619 632.
24. Hsu J. Y., Bourguignon L. Y., Adams C. M., Peyrollier K., Zhang H., Fandel T., Cun C. L., Werb Z. Noble-Haeusslein L. J. (2008) Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord. J. Neurosci. 28, 13467 13477.
25. Hu B., Liu C., Bramlett H., Sick T. J., Alonso O. F., Chen S. Dietrich W. D. (2004) Changes in trkB-ERK1&2-CREB&Elk-1 pathways in hippocampal mossy fiber organization after traumatic brain injury. J. Cereb. Blood Flow Metab. 24, 934 943. (Pubitemid 39045411)
26. Huang T. T., Feinberg S. L., Suryanarayanan S. Miyamoto S. (2002) The zinc finger domain of NEMO is selectively required for NF-κB activation by UV radiation and topoisomerase inhibitors. Mol. Cell. Biol. 22, 5813 5825. (Pubitemid 34815830)
27. Iadecola C. (2004) Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 5, 347 360. (Pubitemid 38568496)
28. Iadecola C. Nedergaard M. (2007) Glial regulation of the cerebral microvasculature. Nat. Neurosci. 10, 1369 1376. (Pubitemid 350014688)
29. Jou T. C., Jou M. J., Chen J. Y. Lee S. Y. (1985) Properties of rat brain astrocytes in long-term culture. Taiwan Yi Xue Hui Za Zhi 84, 865 881.
30. Kam A. Y., Liu A. M. Wong Y. H. (2007) Formyl peptide-receptor like-1 requires lipid raft and extracellular signal-regulated protein kinase to activate inhibitor-κB kinase in human U87 astrocytoma cells. J. Neurochem. 103, 1553 1566.
31. Krupinski J., Slevin M. Badimon L. (2005) Citicoline inhibits MAP kinase signalling pathways after focal cerebral ischaemia. Neurochem. Res. 30, 1067 1073. (Pubitemid 41570042)
32. Lauffenburger D. A. Horwitz A. F. (1996) Cell migration: a physically integrated molecular process. Cell 84, 359 369.
33. Lee W. J., Shin C. Y., Yoo B. K., Ryu J. R., Choi E. Y., Cheong J. H., Ryu J. H. Ko K. H. (2003) Induction of matrix metalloproteinase-9 (MMP-9) in lipopolysaccharide-stimulated primary astrocytes is mediated by extracellular signal-regulated protein kinase 1&2 (Erk1&2). Glia 41, 15 24.
34. Levin E. R. (1995) Endothelins. N. Engl. J. Med. 333, 356 363.
35. Lo A. C., Chen A. Y., Hung V. K., Yaw L. P., Fung M. K., Ho M. C., Tsang M. C., Chung S. S. Chung S. K. (2005) Endothelin-1 overexpression leads to further water accumulation and brain edema after middle cerebral artery occlusion via aquaporin 4 expression in astrocytic end-feet. J. Cereb. Blood Flow Metab. 25, 998 1011.
36. Lund A. K., Lucero J., Lucas S., Madden M. C., McDonald J. D., Seagrave J. C., Knuckles T. L. Campen M. J. (2009) Vehicular emissions induce vascular MMP-9 expression and activity associated with endothelin-1-mediated pathways. Arterioscler. Thromb. Vasc. Biol. 29, 511 517.
37. Mantuano E., Inoue G., Li X., Takahashi K., Gaultier A., Gonias S. L. Campana W. M. (2008) The hemopexin domain of matrix metalloproteinase-9 activates cell signaling and promotes migration of schwann cells by binding to low-density lipoprotein receptor-related protein. J. Neurosci. 28, 11571 11582.
38. McColl B. W., Rothwell N. J. Allan S. M. (2008) Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J. Neurosci. 28, 9451 9462.
39. Mizuno N., Kokubu H., Sato M., Nishimura A., Yamauchi J., Kurose H. Itoh H. (2005) G protein-coupled receptor signaling through Gq and JNK negatively regulates neural progenitor cell migration. Proc. Natl Acad. Sci. USA 102, 12365 12370. (Pubitemid 41266365)
40. Morigi M., Buelli S., Zanchi C., Longaretti L., Macconi D., Benigni A., Moioli D., Remuzzi G. Zoja C. (2006) Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling. Am. J. Pathol. 169, 1965 1975. (Pubitemid 351181958)
41. Nakagomi S., Kiryu-Seo S. Kiyama H. (2000) Endothelin-converting enzymes and endothelin receptor B messenger RNAs are expressed in different neural cell species and these messenger RNAs are coordinately induced in neurons and astrocytes respectively following nerve injury. Neuroscience 101, 441 449.
42. Park S. K., Hwang Y. S., Park K. K., Park H. J., Seo J. Y. Chung W. Y. (2009) Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K&Akt- and PKC-mediated signaling in MCF-7 human breast cancer cells. Carcinogenesis 30, 1225 1233.
43. Rogers S. D., Peters C. M., Pomonis J. D., Hagiwara H., Ghilardi J. R. Mantyh P. W. (2003) Endothelin B receptors are expressed by astrocytes and regulate astrocyte hypertrophy in the normal and injured CNS. Glia 41, 180 190. (Pubitemid 36262195)
44. Rosenberg G. A. (2002) Matrix metalloproteinases in neuroinflammation. Glia 39, 279 291.
45. Rubanyi G. M. Polokoff M. A. (1994) Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46, 325 415.
46. Saadoun S. García A. (1999) Endothelin stimulates nitric oxide-dependent cyclic GMP formation in rat cerebellar astroglia. Neuroreport 10, 33 36. (Pubitemid 29090473)
47. Sachidanandam K., Portik-Dobos V., Harris A. K., Hutchinson J. R., Muller E., Johnson M. H. Ergul A. (2007) Evidence for vasculoprotective effects of ETB receptors in resistance artery remodeling in diabetes. Diabetes 56, 2753 2758. (Pubitemid 350044918)
48. Schinelli S., Zanassi P., Paolillo M., Wang H., Feliciello A. Gallo V. (2001) Stimulation of endothelin B receptors in astrocytes induces cAMP response element-binding protein phosphorylation and c-fos expression via multiple mitogen-activated protein kinase signaling pathways. J. Neurosci. 21, 8842 8853. (Pubitemid 33054848)
49. Shaulian E. Karin M. (2001) AP-1 in cell proliferation and survival. Oncogene 20, 2390 2400. (Pubitemid 32531297)
50. Svedin P., Hagberg H., Sävman K., Zhu C. Mallard C. (2007) Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J. Neurosci. 27, 1511 1518. (Pubitemid 46280068)
51. Tai K. Y., Shieh Y. S., Lee C. S., Shiah S. G. Wu C. W. (2008) Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-κB and Brg-1. Oncogene 27, 4044 4055.
52. Takenaga K. Kozlova E. N. (2006) Role of intracellular S100A4 for migration of rat astrocytes. Glia 53, 313 321. (Pubitemid 43221352)
53. Tanimura S., Nomura K., Ozaki K., Tsujimoto M., Kondo T. Kohno M. (2002) Prolonged nuclear retention of activated extracellular signal-regulated kinase 1&2 is required for hepatocyte growth factor-induced cell motility. J. Biol. Chem. 277, 28256 28264. (Pubitemid 34966780)
54. Wang X., Mori T., Jung J. C., Fini M. E. Lo E. H. (2002) Secretion of matrix metalloproteinase-2 and -9 after mechanical trauma injury in rat cortical cultures and involvement of MAP kinase. J. Neurotrauma 19, 615 625. (Pubitemid 34587304)
55. Wang H. H., Hsieh H. L., Wu C. Y., Sun C. C. Yang C. M. (2009) Oxidized low-density lipoprotein induces matrix metalloproteinase-9 expression via a p42&p44 and JNK-dependent AP-1 pathway in brain astrocytes. Glia 57, 24 38.
56. Wang H. H., Hsieh H. L., Wu C. Y. Yang C. M. (2010) Oxidized low-density lipoprotein-induced matrix metalloproteinase-9 expression via PKC-&p42&p44 MAPK&Elk-1 cascade in brain astrocytes. Neurotox. Res. 17, 50 65.
57. Weng C. J., Chau C. F., Hsieh Y. S., Yang S. F. Yen G. C. (2008) Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK&ERK signal transduction pathway and reducing binding activities of NF-κB and AP-1. Carcinogenesis 29, 147 156.
58. Woo C. H., Lim J. H. Kim J. H. (2004) Lipopolysaccharide induces matrix metalloproteinase-9 expression via a mitochondrial reactive oxygen species-p38 kinase-activator protein-1 pathway in Raw 264.7 cells. J. Immunol. 173, 6973 6980.
59. Wu C. Y., Hsieh H. L., Jou M. J. Yang C. M. (2004) Involvement of p42&p44 MAPK, p38 MAPK, JNK and nuclear factor-κB in interleukin-1β-induced matrix metalloproteinase-9 expression in rat brain astrocytes. J. Neurochem. 90, 1477 1488.
60. Wu C. Y., Hsieh H. L., Sun C. C. Yang C. M. (2009) IL-1β induces MMP-9 expression via a Ca(2 +)- dependent CaMKII&JNK&c-JUN cascade in rat brain astrocytes. Glia 57, 1775 1789.
61. Xu J., Kim G. M., Ahmed S. H., Xu J., Yan P., Xu X. M. Hsu C. Y. (2001) Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury. J. Neurosci. 21, 92 97. (Pubitemid 32098730)
62. Yarbro J. W. (1992) Mechanism of action of hydroxyurea. Semin. Oncol. 19, 1 10.
63. Yong V. W., Krekoski C. A., Forsyth P. A., Bell R. Edwards D. R. (1998) Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21, 75 80.
64. Yong V. W., Power C., Forsyth P. Edwards D. R. (2001) Metalloproteinases in biology and pathology of the nervous system. Nature Rev. Neurosci. 2, 502 511. (Pubitemid 33676585)